These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 22131035)

  • 1. A sensitive and versatile cytokine bioassay based on type I interferon signaling in 2fTGH cells.
    Zabeau L; Van der Heyden J; Tavernier J
    Methods Mol Biol; 2012; 820():231-7. PubMed ID: 22131035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive and versatile bioassay for ligands that signal through receptor clustering.
    Van Ostade X; Schauvliege L; Pattyn E; Verhee A; Vandekerckhove J; Tavernier J
    J Interferon Cytokine Res; 2000 Jan; 20(1):79-87. PubMed ID: 10670654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
    Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
    J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
    Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
    Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerization of chimeric erythropoietin/75 kDa tumour necrosis factor (TNF) receptors transduces TNF signals: necessity for the 75 kDa-TNF receptor transmembrane domain.
    Declercq W; Vandenabeele P; Fiers W
    Cytokine; 1995 Oct; 7(7):701-9. PubMed ID: 8580379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
    Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
    J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human non-small cell lung cancer cells express a type 2 cytokine pattern.
    Huang M; Wang J; Lee P; Sharma S; Mao JT; Meissner H; Uyemura K; Modlin R; Wollman J; Dubinett SM
    Cancer Res; 1995 Sep; 55(17):3847-53. PubMed ID: 7641203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transcriptional effects of interleukin-3, interferon-gamma, erythropoietin and butyrate on in vitro hemoglobin chain synthesis in congenital hemolytic anemia.
    Reinhardt D; Ridder R; Kugler W; Pekrun A
    Haematologica; 2001 Aug; 86(8):791-800. PubMed ID: 11522534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shared receptor components but distinct complexes for alpha and beta interferons.
    Lewerenz M; Mogensen KE; Uzé G
    J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosorbent binding bioassay: a solid phase biological immunoassay for the titration of antisera to alpha interferons.
    L'Haridon RM
    J Immunoassay; 1991; 12(1):99-112. PubMed ID: 2040713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an in vitro potency bioassay for therapeutic IL-13 antagonists: the A-549 cell bioassay.
    Miller R; Sadhukhan R; Wu C
    J Immunol Methods; 2008 May; 334(1-2):134-41. PubMed ID: 18355834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors.
    Oritani K; Medina KL; Tomiyama Y; Ishikawa J; Okajima Y; Ogawa M; Yokota T; Aoyama K; Takahashi I; Kincade PW; Matsuzawa Y
    Nat Med; 2000 Jun; 6(6):659-66. PubMed ID: 10835682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human interleukin 2 analogues that preferentially bind the intermediate-affinity interleukin 2 receptor lead to reduced secondary cytokine secretion: implications for the use of these interleukin 2 analogues in cancer immunotherapy.
    Heaton KM; Ju G; Grimm EA
    Cancer Res; 1993 Jun; 53(11):2597-602. PubMed ID: 8495422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines.
    Wagner B; Robeson J; McCracken M; Wattrang E; Antczak DF
    Vet Immunol Immunopathol; 2005 May; 105(1-2):1-14. PubMed ID: 15797470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble receptor function.
    Schimmenti LA; Blechert G; Harris KW; Winkelmann JC
    Exp Hematol; 1995 Dec; 23(13):1341-6. PubMed ID: 7498361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human type I interferon receptor by ligand blotting.
    Schwabe M; Princler GL; Faltynek CR
    Eur J Immunol; 1988 Dec; 18(12):2009-14. PubMed ID: 2975600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transduction by the chemokine receptor CXCR5: structural requirements for G protein activation analyzed by chimeric CXCR1/CXCR5 molecules.
    Müller G; Lipp M
    Biol Chem; 2001 Sep; 382(9):1387-97. PubMed ID: 11688722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
    Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
    J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.